Inhibitors of the Proteolytic Activity of Urokinase Type Plasminogen Activator
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1483-1498
Author(s):
Todd W. Rockway and Vincent L. Giranda
Structure-Function Relationships in the Interaction Between the Urokinase- Type Plasminogen Activator and Its Receptor
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1499-1528
Author(s):
Michael Ploug
Urokinase-type Plasminogen Activator (uPA) and its Receptor (uPAR): Development of Antagonists of uPA / uPAR Interaction and their Effects In Vitro and In Vivo
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1529-1543
Author(s):
Ute Reuning, Stefan Sperl, Charlotte Kopitz, Horst Kessler, Achim Kruger, Manfred Schmitt and Viktor Magdolen
Plasminogen Activator Inhibitor-1 in Tumor Growth, Angiogenesis and Vascular Remodeling
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1545-1564
Author(s):
Steingrimur Stefansson, Grainne A. McMahon, Eric Petitclerc and Daniel A. Lawrence
Urokinase Receptor and Integrin Interactions
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1565-1574
Author(s):
Matthias C. Kugler, Ying Wei and Harold A. Chapman
Fibroblast Growth Factor Receptor-3 as a Therapeutic Target for Achondroplasia - Genetic Short Limbed Dwarfism
Journal:
Current Drug Targets
Volume:
4
Page:
353-365
Author(s):
David Aviezer, Myriam Golembo and Avner Yayon
Death Receptor Signaling in Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
253-262
Author(s):
Simone Fulda and Klaus-Michael Debatin
Signal Transduction Pathways of Taxanes-Induced Apoptosis
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
291-306
Author(s):
Valerie Ganansia-Leymarie, Pierre Bischoff, Jean-Pierre Bergerat and Vincent Holl
Bcl-2 Proteins: Targets and Tools for Chemosensitisation of Tumor Cells
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
307-318
Author(s):
Ali Bettaieb, Laurence Dubrez-Daloz, Sophie Launay, Stephanie Plenchette, Cedric Rebe, Severine Cathelin and Eric Solary
Molecular Mechanisms and Biological Significance of CTL Avidity
Journal:
Current HIV Research
Volume:
1
Page:
287-294
Author(s):
James T. Snyder, Martha A. Alexander-Miller, Jay A. Berzofsky and Igor M. Belyakov